Arbutus Biopharma (ABUS) Stock: Buy, Sell, or Hold?
ABUS - Arbutus Biopharma Corporation Common Stock
$5.12
0.00 (0.00%)
â˛
5d:
+0.0%
30d:
+11.55%
90d:
+19.35%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 8, 2026 at $5.18 · last confirmed Sep 9, 2026
Strength: 5.1/10
Get Alerted When ABUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ABUS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ABUS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: ABUS is currently trading at $5.12, which is considered slightly high relative to its 30-day fair value range of $4.63 to $5.18.
Technical Outlook: Technically, ABUS is in a strong uptrend. The price is currently testing key support at $4.99. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ABUS scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ABUS is in a strong uptrend. The price is currently testing key support at $4.99. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ABUS scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$4.63 -
$5.18
Company Quality Score
47/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
31.6%
Protect Your Profits
Holding ABUS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Weak technical setup (30/100)
- NEUTRAL: Near Wall St target ($5.51)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.63 -
$5.18
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$4.99
Resistance Level
$5.23
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-46.13
Wall Street Target
$5.51
(+7.6%)
Revenue Growth (YoY)
-90.6%
Profit Margin
84.2%
Share & Embed Analysis
Last updated: September 14, 2026 4:13 AM ET
Data refreshes hourly during market hours. Next update: 5:13 AM
Data refreshes hourly during market hours. Next update: 5:13 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABUS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 32 SELL |
|
REGN
Regeneron PharmaceuticalâĻ |
STRONG BUY
25 analysts |
$849 | 50 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$290 | 59 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
|
MLTX
MoonLake ImmunotherapeutâĻ |
STRONG BUY
16 analysts |
$29 | 41 HOLD |
Advanced ABUS Option Strategies
Professional options setups generated by AI based on today's ABUS price and gamma walls.
